Physician profile
Jaymini Nayee
NPI 1447415732
$2,759.76
in general payments reported to CMS, 2019-2025
19 companies · $14.05 in 2025
The $14.05 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $232 · 2021: $448 · 2022: $916 · 2023: $789 · 2025: $14.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $807.31 | 2019-2023 | Cequa |
| Glaukos Corporation | $308.29 | 2022-2023 | |
| Oyster Point Pharma, INC. | $201.84 | 2022-2023 | Tyrvaya |
| Alcon Vision LLC | $193.35 | 2019-2025 | Eysuvis, Precision7 |
| Allergan, INC. | $150.65 | 2019-2022 | |
| Dompe US, INC. | $138.77 | 2022-2023 | Oxervate |
| Novartis Pharmaceuticals Corporation | $133.53 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $117.51 | 2022-2023 | Xiidra, Miebo, Prolensa |
| Aerie Pharmaceuticals, INC. | $111.35 | 2019 | |
| Sight Sciences, INC. | $108.92 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $90.94 | 2022 | |
| Kala Pharmaceuticals, INC. | $83.62 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $77.17 | 2019-2021 | |
| Abbvie INC. | $67.22 | 2022 | |
| Shire North American Group INC | $65.96 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $35.93 | 2023 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Biotissue Holdings INC. | $35.07 | 2022-2023 | |
| Coopervision INC. | $27.85 | 2022-2023 | Clariti Contact Lens |
| Lkc Technologies, INC. | $4.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaymini Nayee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.